SARS-CoV-2 reinfection

Med Intensiva (Engl Ed). 2021 Aug-Sep;45(6):375-376. doi: 10.1016/j.medine.2021.04.009. Epub 2021 May 2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Aged
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Viral / blood
  • Antigens, Viral / blood
  • Antiviral Agents / therapeutic use
  • COVID-19 / blood
  • COVID-19 / diagnosis
  • COVID-19 / virology*
  • COVID-19 Drug Treatment
  • COVID-19 Nucleic Acid Testing
  • COVID-19 Serological Testing
  • Combined Modality Therapy
  • DNA, Viral / analysis
  • Diabetes Mellitus, Type 2 / complications
  • Drug Therapy, Combination
  • Dyslipidemias / complications
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Hyperuricemia / complications
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Luminescent Measurements
  • Male
  • Methylprednisolone / therapeutic use
  • Nasopharynx / virology
  • Polymerase Chain Reaction
  • Reinfection / blood
  • Reinfection / diagnosis
  • Reinfection / virology*
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / pathogenicity*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • Antigens, Viral
  • Antiviral Agents
  • DNA, Viral
  • Immunoglobulin G
  • Immunoglobulin M
  • remdesivir
  • Adenosine Monophosphate
  • tocilizumab
  • Alanine
  • Methylprednisolone